GLP-1s (Ozempic, Wegovy, Mounjaro, etc.) and cluster headaches: helped, no effect, or worse?
There seems to be growing mechanistic case that GLP-1 drugs (semaglutide, liraglutide, tirzepatide) might help cluster headaches, but I can’t find much real-world cluster experience. And all of it is independent of weight loss.
If you’ve taken a GLP-1 for any reason while also dealing with clusters, I’d love to hear:
1. Did it help your clusters?
2. Did it have no effect?
3. Or did it make them worse?
If you’re willing, please mention which drug, the dose, and whether you’re episodic or chronic. Bonus points for noting whether attack frequency, intensity, or both changed.
The short version of why this might work:
• GLP-1 receptors sit densely in the hypothalamus, which is the region most implicated in generating cluster attacks
• These drugs lower intracranial pressure by reducing how much spinal fluid the brain produces, which may calm the nerves that fire during an attack
• A 2025 pilot study found liraglutide cut monthly migraine days by about 9, and the effect had nothing to do with weight loss. The authors think the drug reduces calcitonin gene-related peptide release upstream, rather than blocking it the way the current cluster preventives do
• A 2023 trial showed exenatide lowered intracranial pressure in patients with idiopathic intracranial hypertension
There are no trials in cluster specifically. Hence the question. Even a handful of data points would be valuable, and if there’s a clear signal I’ll write it up and share back.
Sources:
• Braca et al., Headache 2025: https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14991
• Mitchell et al., Brain 2023: https://pubmed.ncbi.nlm.nih.gov/36907221/
• Krajnc et al., Journal of Headache and Pain 2023: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353241/
• Botfield et al., Science Translational Medicine 2017: https://www.science.org/doi/10.1126/scitranslmed.aan0972